letrozole has been researched along with Cystadenocarcinoma, Serous in 4 studies
Cystadenocarcinoma, Serous: A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole was administered post operatively in 55." | 1.46 | Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? ( Armstrong, DK; Bergstrom, J; DeBernardo, R; Fader, AN; Gaillard, S; Jernigan, A; Levinson, KL; Michener, C; Ricci, S; Roche, KL; Rose, PG; Shih, IM; Stone, RL; Tanner, EJ; Wang, TL; Wethingon, S; Yang, B; Zhang, G, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nica, A | 1 |
| Lee, JYJ | 1 |
| Hong, NL | 1 |
| May, T | 1 |
| Fader, AN | 1 |
| Bergstrom, J | 1 |
| Jernigan, A | 1 |
| Tanner, EJ | 1 |
| Roche, KL | 1 |
| Stone, RL | 1 |
| Levinson, KL | 1 |
| Ricci, S | 1 |
| Wethingon, S | 1 |
| Wang, TL | 1 |
| Shih, IM | 1 |
| Yang, B | 1 |
| Zhang, G | 1 |
| Armstrong, DK | 1 |
| Gaillard, S | 1 |
| Michener, C | 1 |
| DeBernardo, R | 1 |
| Rose, PG | 1 |
| Heinzelmann-Schwarz, V | 1 |
| Knipprath Mészaros, A | 1 |
| Stadlmann, S | 1 |
| Jacob, F | 1 |
| Schoetzau, A | 1 |
| Russell, K | 1 |
| Friedlander, M | 1 |
| Singer, G | 1 |
| Vetter, M | 1 |
| Stanley, B | 1 |
| Hollis, RL | 1 |
| Nunes, H | 1 |
| Towler, JD | 1 |
| Yan, X | 1 |
| Rye, T | 1 |
| Dawson, C | 1 |
| Mackean, MJ | 1 |
| Nussey, F | 1 |
| Churchman, M | 1 |
| Herrington, CS | 1 |
| Gourley, C | 1 |
4 other studies available for letrozole and Cystadenocarcinoma, Serous
| Article | Year |
|---|---|
Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Chemotherapy, Adjuvant; Cost-Benefit Analysi | 2021 |
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; | 2017 |
Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Cohort Studies; Cystadenocarcinoma, Serous; Datasets as Topic; D | 2018 |
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; CA-125 Antigen; Cystadenocarcinoma, | 2019 |